F-group (family)
231.1.1.1 MoCoBD_1
Ligands and drugs
198
Member domains
171
with ligand contacts (≤ 4 Å)
86.4% of members
164
with DrugDomain annotations
82.8% of members
160
with a DrugBank compound
80.8% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 231.1.1.1 belongs to X-group 231 MocoBD/DmpA-related, which binds 9.7 ligand superclasses per 20 proteins, broader than 91% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03328 | MOS | Dioxo(sulfanyl)molybdenum | 67 |
| DB03300 | MCN | Pterin Cytosine Dinucleotide | 23 |
| DB08844 | URC | Uric acid | 23 |
| DB00936 | SAL | Salicylic acid | 18 |
| DB02137 | PCD | Molybdenum cofactor | 17 |
| DB04076 | HPA | Hypoxanthine | 10 |
| DB02134 | XAN | Xanthine | 8 |
| DB05262 | 141 | Oxypurinol | 8 |
| DB03197 | HHR | 6-Hydroxymethylpterin | 4 |
| DB18509 | AST | Arsenite ion | 4 |
| DB11091 | PEO | Hydrogen peroxide | 3 |
| DB01033 | PM6 | Mercaptopurine | 2 |
| DB01685 | FYX | Topiroxostat | 2 |
| DB02377 | GUN | Guanine | 2 |
| DB02580 | PG6 | Pentaglyme | 2 |
| DB03841 | YSH | Niraxostat | 2 |
| DB04216 | QUE | Quercetin | 2 |
| DB04494 | OMO | Dihydroxy(oxo)molybdenum(6+) | 2 |
| DB04854 | TEI | Febuxostat | 2 |
| DB00627 | NIO | Niacin | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| FES | FE2/S2 (INORGANIC) CLUSTER | 159 |
| MTE | PHOSPHONIC ACIDMONO-(2-AMINO-5,6-DIMERCAPTO-4-OXO-3,7,8A,9,10,10A-HEXAHYDRO-4H-8-OXA-1,3,9,10-TETRAAZA-ANTHRACEN-7-YLMETHYL)ESTER | 82 |
| MOS | DIOXOTHIOMOLYBDENUM(VI) ION | 67 |
| CAmetal | CALCIUM ION | 62 |
| MCN | PTERIN CYTOSINE DINUCLEOTIDE | 23 |
| URC | URIC ACID | 23 |
| PCD | (MOLYBDOPTERIN-CYTOSINE DINUCLEOTIDE-S,S)-DIOXO-AQUA-MOLYBDENUM(V) | 18 |
| SAL | 2-HYDROXYBENZOIC ACID | 18 |
| MOM | HYDROXY(DIOXO)MOLYBDENUM | 16 |
| XAX | {[(5aR,8R,9aR)-2-amino-4-oxo-6,7-di(sulfanyl-kappaS)-3,5,5a,8,9a,10-hexahydro-4H-pyrano[3,2-g]pteridin-8-yl]methyl dihydrogenato(2-) phosphate}(hydroxy)oxo(thioxo)molybdenum | 12 |
| HPA | HYPOXANTHINE | 10 |
| CL | CHLORIDE ION | 9 |
| 141 | Oxypurinol | 8 |
| BAmetal | BARIUM ION | 8 |
| XAN | XANTHINE | 8 |
| NAmetal | SODIUM ION | 5 |
| AST | ARSENITE | 4 |
| CUM | CU(I)-S-MO(VI)(=O)OH CLUSTER | 4 |
| CUN | CU(I)-S-MO(IV)(=O)OH CLUSTER | 4 |
| HHR | 6-HYDROXYMETHYLPTERIN | 4 |